Robot-assisted laparoscopic radical prostatectomy in men with human immunodeficiency virus

The aim of this study is to evaluate the outcomes of robot-assisted laparoscopic prostatectomy (RALP) in prostate cancer (PCa) patients with human immunodeficiency virus (HIV). This is a prospective cohort study of HIV patients undergoing RALP, comparing the demographics, tumor characteristics, comp...

Full description

Saved in:
Bibliographic Details
Published inProstate cancer and prostatic diseases Vol. 13; no. 4; pp. 328 - 332
Main Authors Silberstein, J L, Parsons, J K, Palazzi-Churas, K, Downs, T M, Sakamoto, K, Derweesh, I H, Woldrich, J, Kane, C J
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.12.2010
Nature Publishing Group
Subjects
631/250/255/1901
692/699/67/589/466
692/700/565/545
Adult
Aged
Antiretroviral agents
Biomedical and Life Sciences
Biomedicine
Cancer Research
Cancer surgery
Carcinoma - complications
Carcinoma - surgery
Care and treatment
CD4 antigen
Chi-square test
Complications
Demographics
Demography
Diagnosis
Health aspects
Highly active antiretroviral therapy
HIV
HIV - physiology
HIV Infections - complications
HIV Infections - surgery
HIV patients
Human immunodeficiency virus
Humans
Immune system
Laparoscopy
Laparoscopy - instrumentation
Laparoscopy - methods
Length of Stay - statistics & numerical data
Male
Medical examination
Middle Aged
Non-Hodgkin's lymphomas
original-article
Patient outcomes
Patients
Postoperative Complications - epidemiology
Prostate cancer
Prostatectomy
Prostatectomy - instrumentation
Prostatectomy - methods
Prostatic Neoplasms - complications
Prostatic Neoplasms - surgery
Risk factors
Robotic surgery
Robotics - methods
Robots
Statistical tests
Transfusion
Tumors
Urological surgery
United States
AIDS
radical prostatectomy
HIV
robot-assisted laparoscopic prostatectomy
HAART
Online AccessGet full text

Cover

Abstract The aim of this study is to evaluate the outcomes of robot-assisted laparoscopic prostatectomy (RALP) in prostate cancer (PCa) patients with human immunodeficiency virus (HIV). This is a prospective cohort study of HIV patients undergoing RALP, comparing the demographics, tumor characteristics, complications, and short-term oncological outcomes of HIV-positive men to HIV-negative men using univariate ( χ 2 , Mann–Whitney test) and multivariable (logistic regression) analyses. From 2007 to 2010, 298 men underwent RALP, 8 of whom were known to be HIV positive. Preoperatively, all eight were taking highly active antiretroviral therapy (HAART) and had undetectable viral loads (<50); mean CD4 count was 634 cells per mm 3 . HIV-positive men were younger (54 versus 62 years, P =0.010) and less likely to be white ( P =0.007). There were no significant differences between groups with respect to clinical staging, pathological and oncological outcomes or most complication rates. However, the prevalence of perioperative transfusions ( P =0.031) and ileus ( P =0.021) were higher in HIV-positive patients. HIV remained significantly associated with risk of transfusion after adjustment for age, race, Gleason sum and clinical T stage ( P =0.002). After a median of 2.6 (range 0.03–19.2) months of follow-up, PSA remained undetectable in all eight HIV patients. These data suggest that RALP is safe for, and demonstrates short-term oncological efficacy in, HIV-positive patients with PCa.
AbstractList The aim of this study is to evaluate the outcomes of robot-assisted laparoscopic prostatectomy (RALP) in prostate cancer (PCa) patients with human immunodeficiency virus (HIV). This is a prospective cohort study of HIV patients undergoing RALP, comparing the demographics, tumor characteristics, complications, and short-term oncological outcomes of HIV-positive men to HIV-negative men using univariate ( χ 2 , Mann–Whitney test) and multivariable (logistic regression) analyses. From 2007 to 2010, 298 men underwent RALP, 8 of whom were known to be HIV positive. Preoperatively, all eight were taking highly active antiretroviral therapy (HAART) and had undetectable viral loads (<50); mean CD4 count was 634 cells per mm 3 . HIV-positive men were younger (54 versus 62 years, P =0.010) and less likely to be white ( P =0.007). There were no significant differences between groups with respect to clinical staging, pathological and oncological outcomes or most complication rates. However, the prevalence of perioperative transfusions ( P =0.031) and ileus ( P =0.021) were higher in HIV-positive patients. HIV remained significantly associated with risk of transfusion after adjustment for age, race, Gleason sum and clinical T stage ( P =0.002). After a median of 2.6 (range 0.03–19.2) months of follow-up, PSA remained undetectable in all eight HIV patients. These data suggest that RALP is safe for, and demonstrates short-term oncological efficacy in, HIV-positive patients with PCa.
The aim of this study is to evaluate the outcomes of robot-assisted laparoscopic prostatectomy (RALP) in prostate cancer (PCa) patients with human immunodeficiency virus (HIV). This is a prospective cohort study of HIV patients undergoing RALP, comparing the demographics, tumor characteristics, complications, and short-term oncological outcomes of HIV-positive men to HIV-negative men using univariate (χ2, Mann–Whitney test) and multivariable (logistic regression) analyses. From 2007 to 2010, 298 men underwent RALP, 8 of whom were known to be HIV positive. Preoperatively, all eight were taking highly active antiretroviral therapy (HAART) and had undetectable viral loads (<50); mean CD4 count was 634 cells per mm3. HIV-positive men were younger (54 versus 62 years, P=0.010) and less likely to be white (P=0.007). There were no significant differences between groups with respect to clinical staging, pathological and oncological outcomes or most complication rates. However, the prevalence of perioperative transfusions (P=0.031) and ileus (P=0.021) were higher in HIV-positive patients. HIV remained significantly associated with risk of transfusion after adjustment for age, race, Gleason sum and clinical T stage (P=0.002). After a median of 2.6 (range 0.03–19.2) months of follow-up, PSA remained undetectable in all eight HIV patients. These data suggest that RALP is safe for, and demonstrates short-term oncological efficacy in, HIV-positive patients with PCa.
The aim of this study is to evaluate the outcomes of robot-assisted laparoscopic prostatectomy (RALP) in prostate cancer (PCa) patients with human immunodeficiency virus (HIV). This is a prospective cohort study of HIV patients undergoing RALP, comparing the demographics, tumor characteristics, complications, and short-term oncological outcomes of HIV-positive men to HIV-negative men using univariate (χ(2), Mann-Whitney test) and multivariable (logistic regression) analyses. From 2007 to 2010, 298 men underwent RALP, 8 of whom were known to be HIV positive. Preoperatively, all eight were taking highly active antiretroviral therapy (HAART) and had undetectable viral loads (&lt;50); mean CD4 count was 634 cells per mm(3). HIV-positive men were younger (54 versus 62 years, P=0.010) and less likely to be white (P=0.007). There were no significant differences between groups with respect to clinical staging, pathological and oncological outcomes or most complication rates. However, the prevalence of perioperative transfusions (P=0.031) and ileus (P=0.021) were higher in HIV-positive patients. HIV remained significantly associated with risk of transfusion after adjustment for age, race, Gleason sum and clinical T stage (P=0.002). After a median of 2.6 (range 0.03-19.2) months of follow-up, PSA remained undetectable in all eight HIV patients. These data suggest that RALP is safe for, and demonstrates short-term oncological efficacy in, HIV-positive patients with PCa.
The aim of this study is to evaluate the outcomes of robot-assisted laparoscopic prostatectomy (RALP) in prostate cancer (PCa) patients with human immunodeficiency virus (HIV). This is a prospective cohort study of HIV patients undergoing RALP, comparing the demographics, tumor characteristics, complications, and short-term oncological outcomes of HIV-positive men to HIV-negative men using univariate ([chi square], Mann-Whitney test) and multivariable (logistic regression) analyses. From 2007 to 2010, 298 men underwent RALP, 8 of whom were known to be HIV positive. Preoperatively, all eight were taking highly active antiretroviral therapy (HAART) and had undetectable viral loads (<50); mean CD4 count was 634 cells per [mm.sup.3]. HIV-positive men were younger (54 versus 62 years, P = 0.010) and less likely to be white (P = 0.007). There were no significant differences between groups with respect to clinical staging, pathological and oncological outcomes or most complication rates. However, the prevalence of perioperative transfusions (P = 0.031) and ileus (P = 0.021) were higher in HIV-positive patients. HIV remained significantly associated with risk of transfusion after adjustment for age, race, Gleason sum and clinical T stage (P = 0.002). After a median of 2.6 (range 0.03-19.2) months of follow-up, PSA remained undetectable in all eight HIV patients. These data suggest that RALP is safe for, and demonstrates short-term oncological efficacy in, HIV-positive patients with PCa.
The aim of this study is to evaluate the outcomes of robot-assisted laparoscopic prostatectomy (RALP) in prostate cancer (PCa) patients with human immunodeficiency virus (HIV). This is a prospective cohort study of HIV patients undergoing RALP, comparing the demographics, tumor characteristics, complications, and short-term oncological outcomes of HIV-positive men to HIV-negative men using univariate ([chi square], Mann-Whitney test) and multivariable (logistic regression) analyses. From 2007 to 2010, 298 men underwent RALP, 8 of whom were known to be HIV positive. Preoperatively, all eight were taking highly active antiretroviral therapy (HAART) and had undetectable viral loads (<50); mean CD4 count was 634 cells per [mm.sup.3]. HIV-positive men were younger (54 versus 62 years, P = 0.010) and less likely to be white (P = 0.007). There were no significant differences between groups with respect to clinical staging, pathological and oncological outcomes or most complication rates. However, the prevalence of perioperative transfusions (P = 0.031) and ileus (P = 0.021) were higher in HIV-positive patients. HIV remained significantly associated with risk of transfusion after adjustment for age, race, Gleason sum and clinical T stage (P = 0.002). After a median of 2.6 (range 0.03-19.2) months of follow-up, PSA remained undetectable in all eight HIV patients. These data suggest that RALP is safe for, and demonstrates short-term oncological efficacy in, HIV-positive patients with PCa. Prostate Cancer and Prostatic Diseases (2010) 13, 328-332; doi: 10.1038/pcan.2010.35; published online 28 September 2010 Keywords: HIV; AIDS; robot-assisted laparoscopic prostatectomy; HAART; radical prostatectomy
The aim of this study is to evaluate the outcomes of robot-assisted laparoscopic prostatectomy (RALP) in prostate cancer (PCa) patients with human immunodeficiency virus (HIV). This is a prospective cohort study of HIV patients undergoing RALP, comparing the demographics, tumor characteristics, complications, and short-term oncological outcomes of HIV-positive men to HIV-negative men using univariate (χ(2), Mann-Whitney test) and multivariable (logistic regression) analyses. From 2007 to 2010, 298 men underwent RALP, 8 of whom were known to be HIV positive. Preoperatively, all eight were taking highly active antiretroviral therapy (HAART) and had undetectable viral loads (<50); mean CD4 count was 634 cells per mm(3). HIV-positive men were younger (54 versus 62 years, P=0.010) and less likely to be white (P=0.007). There were no significant differences between groups with respect to clinical staging, pathological and oncological outcomes or most complication rates. However, the prevalence of perioperative transfusions (P=0.031) and ileus (P=0.021) were higher in HIV-positive patients. HIV remained significantly associated with risk of transfusion after adjustment for age, race, Gleason sum and clinical T stage (P=0.002). After a median of 2.6 (range 0.03-19.2) months of follow-up, PSA remained undetectable in all eight HIV patients. These data suggest that RALP is safe for, and demonstrates short-term oncological efficacy in, HIV-positive patients with PCa.
The aim of this study is to evaluate the outcomes of robot-assisted laparoscopic prostatectomy (RALP) in prostate cancer (PCa) patients with human immunodeficiency virus (HIV). This is a prospective cohort study of HIV patients undergoing RALP, comparing the demographics, tumor characteristics, complications, and short-term oncological outcomes of HIV-positive men to HIV-negative men using univariate ( chi super(2), Mann-Whitney test) and multivariable (logistic regression) analyses. From 2007 to 2010, 298 men underwent RALP, 8 of whom were known to be HIV positive. Preoperatively, all eight were taking highly active antiretroviral therapy (HAART) and had undetectable viral loads (<50); mean CD4 count was 634 cells per mm super(3). HIV-positive men were younger (54 versus 62 years, P=0.010) and less likely to be white (P=0.007). There were no significant differences between groups with respect to clinical staging, pathological and oncological outcomes or most complication rates. However, the prevalence of perioperative transfusions (P=0.031) and ileus (P=0.021) were higher in HIV-positive patients. HIV remained significantly associated with risk of transfusion after adjustment for age, race, Gleason sum and clinical T stage (P=0.002). After a median of 2.6 (range 0.03-19.2) months of follow-up, PSA remained undetectable in all eight HIV patients. These data suggest that RALP is safe for, and demonstrates short-term oncological efficacy in, HIV-positive patients with PCa.
Audience Academic
Author Woldrich, J
Silberstein, J L
Derweesh, I H
Parsons, J K
Sakamoto, K
Palazzi-Churas, K
Downs, T M
Kane, C J
Author_xml – sequence: 1
  givenname: J L
  surname: Silberstein
  fullname: Silberstein, J L
  email: leparker@ucsd.edu
  organization: Division of Urology, University of California San Diego, Urologic Cancer Unit, Moores University of California San Diego Cancer Center, Section of Urology, VA San Diego Medical Center
– sequence: 2
  givenname: J K
  surname: Parsons
  fullname: Parsons, J K
  organization: Division of Urology, University of California San Diego, Urologic Cancer Unit, Moores University of California San Diego Cancer Center, Section of Urology, VA San Diego Medical Center
– sequence: 3
  givenname: K
  surname: Palazzi-Churas
  fullname: Palazzi-Churas, K
  organization: Urologic Cancer Unit, Moores University of California San Diego Cancer Center
– sequence: 4
  givenname: T M
  surname: Downs
  fullname: Downs, T M
  organization: Division of Urology, University of California San Diego, Urologic Cancer Unit, Moores University of California San Diego Cancer Center, Section of Urology, VA San Diego Medical Center
– sequence: 5
  givenname: K
  surname: Sakamoto
  fullname: Sakamoto, K
  organization: Division of Urology, University of California San Diego, Section of Urology, VA San Diego Medical Center
– sequence: 6
  givenname: I H
  surname: Derweesh
  fullname: Derweesh, I H
  organization: Division of Urology, University of California San Diego, Urologic Cancer Unit, Moores University of California San Diego Cancer Center, Section of Urology, VA San Diego Medical Center
– sequence: 7
  givenname: J
  surname: Woldrich
  fullname: Woldrich, J
  organization: Division of Urology, University of California San Diego, Urologic Cancer Unit, Moores University of California San Diego Cancer Center, Section of Urology, VA San Diego Medical Center
– sequence: 8
  givenname: C J
  surname: Kane
  fullname: Kane, C J
  organization: Division of Urology, University of California San Diego, Urologic Cancer Unit, Moores University of California San Diego Cancer Center, Section of Urology, VA San Diego Medical Center
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20877308$$D View this record in MEDLINE/PubMed
BookMark eNqF0ttr1TAYAPAgE3fRN58lKMwXe0ya5tLHMeYFBoLoiy8hTZOdjDapuSjnvzflzM2Jw_Qhafr7vuYj3zE48MEbAJ5jtMGIiLeLVn7TovpK6CNwhDvOGsqQOKhrwmjDBW0PwXFK1wihHvfoCThskeCcIHEEvn0OQ8iNSsmlbEY4qUXFkHRYnIZRjU6rCS51J6tsdA7zDjoPZ-PhT5e3cFtm5aGb5-LDaKzTzni9gz9cLOkpeGzVlMyzm_kEfH138eX8Q3P56f3H87PLRlPOcmMHSyhtLbUaYyQo1gx1PUbUDoopykfGhKJspKgTRgiFe6G7rhN9PwxiMJqcgNf7vPWY34tJWc4uaTNNyptQkhSctS3BpP-v5KyjCDFBqnz5l7wOJfpaRkWkDsZpRa8eQm3NRLCgHb9TV2oy0nkbclR6_bE8a7uWcNKL9Wibf6j6jGZ2ut64dXX_XsDpHwFbo6a8TWEq2QWf7sM3e6jrLaZorFyim1XcSYzk2kFy7SC5dpAka1Evbooqw2zGW_y7ZSpo9iDVT_7KxLuqH0gI996rXKK5Tbii1VTyC9Ng2nM
CitedBy_id crossref_primary_10_1016_j_urolonc_2020_07_027
crossref_primary_10_1158_1055_9965_EPI_14_0614
crossref_primary_10_1007_s11255_016_1338_4
crossref_primary_10_1016_j_surg_2016_09_035
crossref_primary_10_1007_s11255_019_02321_z
Cites_doi 10.1158/1055-9965.EPI-07-0042
10.3322/caac.20006
10.1016/j.juro.2007.03.003
10.1038/pcan.2008.44
10.1038/pcan.2009.17
10.7326/0003-4819-146-2-200701160-00003
10.1097/01.sla.0000133083.54934.ae
10.1177/145749690909800203
10.1097/QAI.0b013e3181576818
10.1002/cncr.20389
10.1111/j.1468-1293.2006.00410.x
10.3322/CA.2007.0010
10.1093/aje/kwn361
10.1016/S0090-4295(95)96214-X
10.1097/01.aids.0000238411.75324.59
10.1016/j.urology.2004.08.053
10.1100/tsw.2009.20
10.1001/jama.300.5.520
10.1016/j.urology.2008.01.022
10.1001/archsurg.141.12.1238
10.1016/j.urology.2007.11.026
10.1111/j.1464-410X.2006.06271.x
10.6004/jnccn.2010.0016
10.3816/CGC.2006.n.023
ContentType Journal Article
Copyright Macmillan Publishers Limited 2010
COPYRIGHT 2010 Nature Publishing Group
Macmillan Publishers Limited 2010.
Copyright Nature Publishing Group Dec 2010
Copyright_xml – notice: Macmillan Publishers Limited 2010
– notice: COPYRIGHT 2010 Nature Publishing Group
– notice: Macmillan Publishers Limited 2010.
– notice: Copyright Nature Publishing Group Dec 2010
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7TO
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
M7Z
P64
PQEST
PQQKQ
PQUKI
PRINS
7X8
7U9
DOI 10.1038/pcan.2010.35
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
Medical Database
Biological Science Database
Biochemistry Abstracts 1
Biotechnology and BioEngineering Abstracts
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
Virology and AIDS Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
Technology Research Database
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Medical Library (Alumni)
ProQuest Public Health
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Biochemistry Abstracts 1
Engineering Research Database
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
Virology and AIDS Abstracts
DatabaseTitleList
ProQuest Central Student
MEDLINE - Academic


MEDLINE

ProQuest Central Student
AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1476-5608
EndPage 332
ExternalDocumentID 2185856061
A242373989
10_1038_pcan_2010_35
20877308
pcan201035
Genre Clinical Trial
Journal Article
GeographicLocations United States
GeographicLocations_xml – name: United States
GroupedDBID -
-Q-
0R
123
29P
2WC
39C
3V.
4.4
53G
70F
7X7
88E
8AO
8C1
8FI
8FJ
8R4
8R5
AADWK
AAPBV
AAWBL
AAYJO
AAZLF
ABAWZ
ABDBF
ABDEU
ABFLS
ABPTK
ABUWG
ACGFS
ACIWK
ACKTT
ACPRK
ADACO
ADBBV
ADHDB
ADQMX
AEDAW
AEJRE
AENEX
AEXYK
AFKRA
AFRAH
AFSHS
AGEZK
AHMBA
AHSBF
AJRNO
ALFFA
ALMA_UNASSIGNED_HOLDINGS
AXYYD
B0M
BAWUL
BBAFP
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
CAG
COF
CS3
DIK
DU5
E3Z
EAD
EAP
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMK
EPL
ESX
F5P
FDQFY
FERAY
FIZPM
FYUFA
HCIFZ
HZ
IAO
IHR
IHW
INH
INR
ITC
JSO
KQ8
M1P
M7P
NAO
O9-
OK1
OVD
P2P
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
Q-
Q2X
RIG
RNS
RNT
RNTTT
SNX
SNYQT
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TEORI
TR2
TSG
TUS
UDS
W2D
---
0R~
36B
406
AACDK
AANZL
AASML
AATNV
ABAKF
ABJNI
ABZZP
ACAOD
ACRQY
ACZOJ
AEFQL
AEMSY
AEVLU
AFBBN
AGAYW
AGHAI
AGQEE
AIGIU
AILAN
ALIPV
AMYLF
CCPQU
DNIVK
DPUIP
EMOBN
FIGPU
HMCUK
HZ~
IWAJR
JZLTJ
NQJWS
SOHCF
SRMVM
UKHRP
~8M
AAYZH
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
AAYFA
ABGIJ
ACBMV
ACBRV
ACBYP
ACIGE
ACTTH
ACVWB
ADMDM
ADYYL
AEFTE
AFNRJ
AGGBP
AJCLW
AJDOV
AMRJV
NYICJ
7TO
7XB
8FD
8FE
8FH
8FK
AZQEC
DWQXO
FR3
GNUQQ
H94
K9.
LK8
M7Z
P64
7X8
7U9
ID FETCH-LOGICAL-c576t-fbf3552f5fc110851c6049105fba6a57d668a56d5048e88a198c444899bb8bec3
IEDL.DBID BENPR
ISSN 1365-7852
IngestDate Fri Aug 16 12:03:44 EDT 2024
Fri Aug 16 00:36:27 EDT 2024
Thu Oct 10 22:39:44 EDT 2024
Thu Oct 10 22:44:22 EDT 2024
Thu Feb 22 23:50:59 EST 2024
Fri Feb 02 03:54:13 EST 2024
Tue Aug 20 22:00:49 EDT 2024
Thu Sep 12 19:28:12 EDT 2024
Tue Oct 15 23:37:32 EDT 2024
Fri Oct 11 20:46:41 EDT 2024
Thu Oct 07 19:31:17 EDT 2021
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords AIDS
radical prostatectomy
HIV
robot-assisted laparoscopic prostatectomy
HAART
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c576t-fbf3552f5fc110851c6049105fba6a57d668a56d5048e88a198c444899bb8bec3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink http://dx.doi.org/10.1038/pcan.2010.35
PMID 20877308
PQID 2645318547
PQPubID 27992
PageCount 5
ParticipantIDs proquest_miscellaneous_876223139
proquest_miscellaneous_764500683
proquest_journals_763333675
proquest_journals_2645318547
gale_infotracmisc_A242373989
gale_infotracacademiconefile_A242373989
gale_healthsolutions_A242373989
crossref_primary_10_1038_pcan_2010_35
pubmed_primary_20877308
springer_journals_10_1038_pcan_2010_35
nature_primary_pcan201035
ProviderPackageCode ABDEU
AEDAW
AAZLF
-Q-
AADWK
AAYJO
70F
ADQMX
EE.
RNTTT
SWTZT
RNT
NAO
PublicationCentury 2000
PublicationDate 2010-12-01
PublicationDateYYYYMMDD 2010-12-01
PublicationDate_xml – month: 12
  year: 2010
  text: 2010-12-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
– name: Houndmills
PublicationTitle Prostate cancer and prostatic diseases
PublicationTitleAbbrev Prostate Cancer Prostatic Dis
PublicationTitleAlternate Prostate Cancer Prostatic Dis
PublicationYear 2010
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References O'Connor, JK, Nedzi, LA, Zakris, EL 2006; 5
Horberg, MA, Hurley, LB, Klein, DB, Follansbee, SE, Quesenberry, C, Flamm, JA 2006; 141
Hsiao, W, Anastasia, K, Hall, J, Goodman, M, Rimland, D, Ritenour, CW, Issa, MM 2009; 9
Kwan, DJ, Lowe, FC 1995; 45
Huang, WC, Kwon, EO, Scardino, PT, Eastham, JA 2006; 98
Ng, T, Stein, NF, Kaminetsky, J, Berman, S, Marans, HY, McDermott, B 2008; 72
Thompson, I, Thrasher, JB, Aus, G, Burnett, AL, Canby-Hagino, ED, Cookson, MS 2007; 177
2008
Vianna, LE, Lo, Y, Klein, RS 2006; 7
Levinson, A, Nagler, EA, Lowe, FC 2005; 65
Glynn, M, Rhodes, P
Jemal, A, Siegel, R, Ward, E, Hao, Y, Xu, J, Thun, MJ 2009; 59
Engels, EA, Pfeiffer, RM, Goedert, JJ, Virgo, P, McNeel, TS, Scoppa, SM 2006; 20
Hall, HI, Song, R, Rhodes, P, Prejean, J, An, Q, Lee, LM 2008; 300
Lohse, N, Hansen, AB, Pedersen, G, Kronborg, G, Gerstoft, J, Sorensen, HT 2007; 146
Kawachi, MH, Bahnson, RR, Barry, M, Busby, JE, Carroll, PR, Carter, HB 2010; 8
Orvieto, MA, Patel, VR 2009; 98
Crum, NF, Spencer, CR, Amling, CL 2004; 101
Silberstein, JL, Derweesh, IH, Kane, CJ 2009; 12
Vellozzi, C, Brooks, JT, Bush, TJ, Conley, LJ, Henry, K, Carpenter, CC 2009; 169
Dindo, D, Demartines, N, Clavien, PA 2004; 240
Jemal, A, Siegel, R, Ward, E, Hao, Y, Xu, J, Murray, T 2008; 58
Goedert, JJ, Purdue, MP, McNeel, TS, McGlynn, KA, Engels, EA 2007; 16
2005; 54
Parsons, JK, Bennett, JL 2008; 72
Lewden, C, Chene, G, Morlat, P, Raffi, F, Dupon, M, Dellamonica, P 2007; 46
Silberstein, J, Downs, T, Lakin, C, Kane, CJ 2009; 12
DindoDDemartinesNClavienPAClassification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a surveyAnn Surg200424020521310.1097/01.sla.0000133083.54934.ae152735421360123
HsiaoWAnastasiaKHallJGoodmanMRimlandDRitenourCWIssaMMAssociation between HIV status and positive prostate biopsy in a study of US veteransScientificWorldJournal2009910210810.1100/tsw.2009.20192193745823076
ParsonsJKBennettJLOutcomes of retropubic, laparoscopic, and robotic-assisted prostatectomyUrology20087241241610.1016/j.urology.2007.11.02618267330
OrvietoMAPatelVREvolution of robot-assisted radical prostatectomyScand J Surg20099876881:STN:280:DC%2BD1Mnms1CrtQ%3D%3D10.1177/14574969090980020319799045
NgTSteinNFKaminetskyJBermanSMaransHYMcDermottBPreliminary results of radiation therapy for prostate cancer in human immunodeficiency virus-positive patientsUrology2008721135113810.1016/j.urology.2008.01.02218407325
KwanDJLoweFCGenitourinary manifestations of the acquired immunodeficiency syndromeUrology19954513271:STN:280:DyaK2M7hslajtA%3D%3D10.1016/S0090-4295(95)96214-X7817465
VellozziCBrooksJTBushTJConleyLJHenryKCarpenterCCThe study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study)Am J Epidemiol200916964265210.1093/aje/kwn36119074775
KawachiMHBahnsonRRBarryMBusbyJECarrollPRCarterHBNCCN Clinical Practice Guidelines in Oncology: prostate cancer early detectionJ Natl Compr Canc Netw201082402621:CAS:528:DC%2BC3cXjt1WltLs%3D10.6004/jnccn.2010.001620141680
O’ConnorJKNedziLAZakrisELProstate adenocarcinoma and human immunodeficiency virus: report of three cases and review of the literatureClin Genitourin Cancer20065858810.3816/CGC.2006.n.02316859585
HallHISongRRhodesPPrejeanJAnQLeeLMEstimation of HIV incidence in the United StatesJAMA20083005205291:CAS:528:DC%2BD1cXps1ygtrY%3D10.1001/jama.300.5.520186770242919237
ViannaLELoYKleinRSSerum prostate-specific antigen levels in older men with or at risk of HIV infectionHIV Med200674714761:STN:280:DC%2BD28rgtFygug%3D%3D10.1111/j.1468-1293.2006.00410.x169257342435169
LohseNHansenABPedersenGKronborgGGerstoftJSorensenHTSurvival of persons with and without HIV infection in Denmark, 1995-2005Ann Intern Med2007146879510.7326/0003-4819-146-2-200701160-0000317227932
LevinsonANaglerEALoweFCApproach to management of clinically localized prostate cancer in patients with human immunodeficiency virusUrology200565919410.1016/j.urology.2004.08.05315667871
JemalASiegelRWardEHaoYXuJMurrayTCancer statistics, 2008CA Cancer J Clin200858719610.3322/CA.2007.001018287387
HorbergMAHurleyLBKleinDBFollansbeeSEQuesenberryCFlammJASurgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapyArch Surg20061411238124510.1001/archsurg.141.12.123817178967
JemalASiegelRWardEHaoYXuJThunMJCancer statistics, 2009CA Cancer J Clin20095922524910.3322/caac.2000619474385
SilbersteinJLDerweeshIHKaneCJLymph node dissection during robot-assisted radical prostatectomy: where do we stand?Prostate Cancer Prostatic Dis2009122272321:STN:280:DC%2BD1MrptFCmsQ%3D%3D10.1038/pcan.2009.1719546882
Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2006. US Department of Health and Human Services, Centers for Disease Control and Prevention: Atlanta, GA, 2008.
GoedertJJPurdueMPMcNeelTSMcGlynnKAEngelsEARisk of germ cell tumors among men with HIV/acquired immunodeficiency syndromeCancer Epidemiol Biomarkers Prev200716126612691:CAS:528:DC%2BD2sXmtVKntb4%3D10.1158/1055-9965.EPI-07-004217548695
SilbersteinJDownsTLakinCKaneCJHIV and prostate cancer: a systematic review of the literatureProstate Cancer Prostatic Dis2009126121:STN:280:DC%2BD1M7isl2kuw%3D%3D10.1038/pcan.2008.4418711409
Glynn M, Rhodes P . Estimated HIV prevalence in the United States at the end of 200. National HIV Prevention Conference. Atlanta, GA.
CrumNFSpencerCRAmlingCLProstate carcinoma among men with human immunodeficiency virus infectionCancer200410129429910.1002/cncr.2038915241826
EngelsEAPfeifferRMGoedertJJVirgoPMcNeelTSScoppaSMTrends in cancer risk among people with AIDS in the United States 1980-2002AIDS2006201645165410.1097/01.aids.0000238411.75324.59
LewdenCCheneGMorlatPRaffiFDuponMDellamonicaPHIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general populationJ Acquir Immune Defic Syndr200746727710.1097/QAI.0b013e318157681817621240
HuangWCKwonEOScardinoPTEasthamJARadical prostatectomy in patients infected with human immunodeficiency virusBJU Int20069830330710.1111/j.1464-410X.2006.06271.x168796692239296
Centers for Disease Control and PreventionTrends in HIV/AIDS diagnoses—33 states, 2001-2004MMWR Morb Mortal Wkly Rep20055411491153
ThompsonIThrasherJBAusGBurnettALCanby-HaginoEDCooksonMSGuideline for the management of clinically localized prostate cancer: 2007 updateJ Urol20071772106213110.1016/j.juro.2007.03.00317509297
JL Silberstein (BFpcan201035_CR15) 2009; 12
LE Vianna (BFpcan201035_CR11) 2006; 7
I Thompson (BFpcan201035_CR19) 2007; 177
JJ Goedert (BFpcan201035_CR9) 2007; 16
D Dindo (BFpcan201035_CR16) 2004; 240
JK Parsons (BFpcan201035_CR27) 2008; 72
EA Engels (BFpcan201035_CR8) 2006; 20
MH Kawachi (BFpcan201035_CR20) 2010; 8
Centers for Disease Control and Prevention (BFpcan201035_CR4) 2005; 54
HI Hall (BFpcan201035_CR2) 2008; 300
C Vellozzi (BFpcan201035_CR6) 2009; 169
A Jemal (BFpcan201035_CR12) 2009; 59
JK O’Connor (BFpcan201035_CR23) 2006; 5
DJ Kwan (BFpcan201035_CR25) 1995; 45
NF Crum (BFpcan201035_CR10) 2004; 101
A Jemal (BFpcan201035_CR13) 2008; 58
WC Huang (BFpcan201035_CR21) 2006; 98
T Ng (BFpcan201035_CR24) 2008; 72
MA Orvieto (BFpcan201035_CR14) 2009; 98
C Lewden (BFpcan201035_CR5) 2007; 46
BFpcan201035_CR1
MA Horberg (BFpcan201035_CR26) 2006; 141
BFpcan201035_CR3
A Levinson (BFpcan201035_CR22) 2005; 65
N Lohse (BFpcan201035_CR7) 2007; 146
W Hsiao (BFpcan201035_CR18) 2009; 9
J Silberstein (BFpcan201035_CR17) 2009; 12
References_xml – volume: 12
  start-page: 6
  year: 2009
  end-page: 12
  article-title: HIV and prostate cancer: a systematic review of the literature
  publication-title: Prostate Cancer Prostatic Dis
  contributor:
    fullname: Kane, CJ
– volume: 45
  start-page: 13
  year: 1995
  end-page: 27
  article-title: Genitourinary manifestations of the acquired immunodeficiency syndrome
  publication-title: Urology
  contributor:
    fullname: Lowe, FC
– volume: 300
  start-page: 520
  year: 2008
  end-page: 529
  article-title: Estimation of HIV incidence in the United States
  publication-title: JAMA
  contributor:
    fullname: Lee, LM
– volume: 98
  start-page: 303
  year: 2006
  end-page: 307
  article-title: Radical prostatectomy in patients infected with human immunodeficiency virus
  publication-title: BJU Int
  contributor:
    fullname: Eastham, JA
– volume: 46
  start-page: 72
  year: 2007
  end-page: 77
  article-title: HIV-infected adults with a CD4 cell count greater than 500 cells mm on long-term combination antiretroviral therapy reach same mortality rates as the general population
  publication-title: J Acquir Immune Defic Syndr
  contributor:
    fullname: Dellamonica, P
– volume: 16
  start-page: 1266
  year: 2007
  end-page: 1269
  article-title: Risk of germ cell tumors among men with HIV acquired immunodeficiency syndrome
  publication-title: Cancer Epidemiol Biomarkers Prev
  contributor:
    fullname: Engels, EA
– article-title: Estimated HIV prevalence in the United States at the end of 200
  publication-title: National HIV Prevention Conference
  contributor:
    fullname: Rhodes, P
– volume: 54
  start-page: 1149
  year: 2005
  end-page: 1153
  article-title: Trends in HIV AIDS diagnoses-33 states, 2001-2004
  publication-title: MMWR Morb Mortal Wkly Rep
– year: 2008
  publication-title: HIV AIDS Surveillance Report, 2006
– volume: 7
  start-page: 471
  year: 2006
  end-page: 476
  article-title: Serum prostate-specific antigen levels in older men with or at risk of HIV infection
  publication-title: HIV Med
  contributor:
    fullname: Klein, RS
– volume: 65
  start-page: 91
  year: 2005
  end-page: 94
  article-title: Approach to management of clinically localized prostate cancer in patients with human immunodeficiency virus
  publication-title: Urology
  contributor:
    fullname: Lowe, FC
– volume: 5
  start-page: 85
  year: 2006
  end-page: 88
  article-title: Prostate adenocarcinoma and human immunodeficiency virus: report of three cases and review of the literature
  publication-title: Clin Genitourin Cancer
  contributor:
    fullname: Zakris, EL
– volume: 8
  start-page: 240
  year: 2010
  end-page: 262
  article-title: NCCN Clinical Practice Guidelines in Oncology: prostate cancer early detection
  publication-title: J Natl Compr Canc Netw
  contributor:
    fullname: Carter, HB
– volume: 72
  start-page: 412
  year: 2008
  end-page: 416
  article-title: Outcomes of retropubic, laparoscopic, and robotic-assisted prostatectomy
  publication-title: Urology
  contributor:
    fullname: Bennett, JL
– volume: 101
  start-page: 294
  year: 2004
  end-page: 299
  article-title: Prostate carcinoma among men with human immunodeficiency virus infection
  publication-title: Cancer
  contributor:
    fullname: Amling, CL
– volume: 146
  start-page: 87
  year: 2007
  end-page: 95
  article-title: Survival of persons with and without HIV infection in Denmark, 1995-2005
  publication-title: Ann Intern Med
  contributor:
    fullname: Sorensen, HT
– volume: 58
  start-page: 71
  year: 2008
  end-page: 96
  article-title: Cancer statistics, 2008
  publication-title: CA Cancer J Clin
  contributor:
    fullname: Murray, T
– volume: 9
  start-page: 102
  year: 2009
  end-page: 108
  article-title: Association between HIV status and positive prostate biopsy in a study of US veterans
  publication-title: ScientificWorldJournal
  contributor:
    fullname: Issa, MM
– volume: 98
  start-page: 76
  year: 2009
  end-page: 88
  article-title: Evolution of robot-assisted radical prostatectomy
  publication-title: Scand J Surg
  contributor:
    fullname: Patel, VR
– volume: 141
  start-page: 1238
  year: 2006
  end-page: 1245
  article-title: Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy
  publication-title: Arch Surg
  contributor:
    fullname: Flamm, JA
– volume: 240
  start-page: 205
  year: 2004
  end-page: 213
  article-title: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey
  publication-title: Ann Surg
  contributor:
    fullname: Clavien, PA
– volume: 72
  start-page: 1135
  year: 2008
  end-page: 1138
  article-title: Preliminary results of radiation therapy for prostate cancer in human immunodeficiency virus-positive patients
  publication-title: Urology
  contributor:
    fullname: McDermott, B
– volume: 20
  start-page: 1645
  year: 2006
  end-page: 1654
  article-title: Trends in cancer risk among people with AIDS in the United States 1980-2002
  publication-title: AIDS
  contributor:
    fullname: Scoppa, SM
– volume: 59
  start-page: 225
  year: 2009
  end-page: 249
  article-title: Cancer statistics, 2009
  publication-title: CA Cancer J Clin
  contributor:
    fullname: Thun, MJ
– volume: 169
  start-page: 642
  year: 2009
  end-page: 652
  article-title: The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study)
  publication-title: Am J Epidemiol
  contributor:
    fullname: Carpenter, CC
– volume: 12
  start-page: 227
  year: 2009
  end-page: 232
  article-title: Lymph node dissection during robot-assisted radical prostatectomy: where do we stand?
  publication-title: Prostate Cancer Prostatic Dis
  contributor:
    fullname: Kane, CJ
– volume: 177
  start-page: 2106
  year: 2007
  end-page: 2131
  article-title: Guideline for the management of clinically localized prostate cancer: 2007 update
  publication-title: J Urol
  contributor:
    fullname: Cookson, MS
– volume: 16
  start-page: 1266
  year: 2007
  ident: BFpcan201035_CR9
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-07-0042
  contributor:
    fullname: JJ Goedert
– volume: 59
  start-page: 225
  year: 2009
  ident: BFpcan201035_CR12
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.20006
  contributor:
    fullname: A Jemal
– volume: 177
  start-page: 2106
  year: 2007
  ident: BFpcan201035_CR19
  publication-title: J Urol
  doi: 10.1016/j.juro.2007.03.003
  contributor:
    fullname: I Thompson
– volume: 12
  start-page: 6
  year: 2009
  ident: BFpcan201035_CR17
  publication-title: Prostate Cancer Prostatic Dis
  doi: 10.1038/pcan.2008.44
  contributor:
    fullname: J Silberstein
– volume: 12
  start-page: 227
  year: 2009
  ident: BFpcan201035_CR15
  publication-title: Prostate Cancer Prostatic Dis
  doi: 10.1038/pcan.2009.17
  contributor:
    fullname: JL Silberstein
– volume: 146
  start-page: 87
  year: 2007
  ident: BFpcan201035_CR7
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-146-2-200701160-00003
  contributor:
    fullname: N Lohse
– volume: 240
  start-page: 205
  year: 2004
  ident: BFpcan201035_CR16
  publication-title: Ann Surg
  doi: 10.1097/01.sla.0000133083.54934.ae
  contributor:
    fullname: D Dindo
– volume: 98
  start-page: 76
  year: 2009
  ident: BFpcan201035_CR14
  publication-title: Scand J Surg
  doi: 10.1177/145749690909800203
  contributor:
    fullname: MA Orvieto
– volume: 46
  start-page: 72
  year: 2007
  ident: BFpcan201035_CR5
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0b013e3181576818
  contributor:
    fullname: C Lewden
– volume: 101
  start-page: 294
  year: 2004
  ident: BFpcan201035_CR10
  publication-title: Cancer
  doi: 10.1002/cncr.20389
  contributor:
    fullname: NF Crum
– volume: 7
  start-page: 471
  year: 2006
  ident: BFpcan201035_CR11
  publication-title: HIV Med
  doi: 10.1111/j.1468-1293.2006.00410.x
  contributor:
    fullname: LE Vianna
– volume: 58
  start-page: 71
  year: 2008
  ident: BFpcan201035_CR13
  publication-title: CA Cancer J Clin
  doi: 10.3322/CA.2007.0010
  contributor:
    fullname: A Jemal
– ident: BFpcan201035_CR1
– ident: BFpcan201035_CR3
– volume: 169
  start-page: 642
  year: 2009
  ident: BFpcan201035_CR6
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwn361
  contributor:
    fullname: C Vellozzi
– volume: 45
  start-page: 13
  year: 1995
  ident: BFpcan201035_CR25
  publication-title: Urology
  doi: 10.1016/S0090-4295(95)96214-X
  contributor:
    fullname: DJ Kwan
– volume: 20
  start-page: 1645
  year: 2006
  ident: BFpcan201035_CR8
  publication-title: AIDS
  doi: 10.1097/01.aids.0000238411.75324.59
  contributor:
    fullname: EA Engels
– volume: 65
  start-page: 91
  year: 2005
  ident: BFpcan201035_CR22
  publication-title: Urology
  doi: 10.1016/j.urology.2004.08.053
  contributor:
    fullname: A Levinson
– volume: 9
  start-page: 102
  year: 2009
  ident: BFpcan201035_CR18
  publication-title: ScientificWorldJournal
  doi: 10.1100/tsw.2009.20
  contributor:
    fullname: W Hsiao
– volume: 300
  start-page: 520
  year: 2008
  ident: BFpcan201035_CR2
  publication-title: JAMA
  doi: 10.1001/jama.300.5.520
  contributor:
    fullname: HI Hall
– volume: 72
  start-page: 1135
  year: 2008
  ident: BFpcan201035_CR24
  publication-title: Urology
  doi: 10.1016/j.urology.2008.01.022
  contributor:
    fullname: T Ng
– volume: 54
  start-page: 1149
  year: 2005
  ident: BFpcan201035_CR4
  publication-title: MMWR Morb Mortal Wkly Rep
  contributor:
    fullname: Centers for Disease Control and Prevention
– volume: 141
  start-page: 1238
  year: 2006
  ident: BFpcan201035_CR26
  publication-title: Arch Surg
  doi: 10.1001/archsurg.141.12.1238
  contributor:
    fullname: MA Horberg
– volume: 72
  start-page: 412
  year: 2008
  ident: BFpcan201035_CR27
  publication-title: Urology
  doi: 10.1016/j.urology.2007.11.026
  contributor:
    fullname: JK Parsons
– volume: 98
  start-page: 303
  year: 2006
  ident: BFpcan201035_CR21
  publication-title: BJU Int
  doi: 10.1111/j.1464-410X.2006.06271.x
  contributor:
    fullname: WC Huang
– volume: 8
  start-page: 240
  year: 2010
  ident: BFpcan201035_CR20
  publication-title: J Natl Compr Canc Netw
  doi: 10.6004/jnccn.2010.0016
  contributor:
    fullname: MH Kawachi
– volume: 5
  start-page: 85
  year: 2006
  ident: BFpcan201035_CR23
  publication-title: Clin Genitourin Cancer
  doi: 10.3816/CGC.2006.n.023
  contributor:
    fullname: JK O’Connor
SSID ssj0009190
Score 1.9841484
Snippet The aim of this study is to evaluate the outcomes of robot-assisted laparoscopic prostatectomy (RALP) in prostate cancer (PCa) patients with human...
SourceID proquest
gale
crossref
pubmed
springer
nature
SourceType Aggregation Database
Index Database
Publisher
StartPage 328
SubjectTerms 631/250/255/1901
692/699/67/589/466
692/700/565/545
Adult
Aged
Antiretroviral agents
Biomedical and Life Sciences
Biomedicine
Cancer Research
Cancer surgery
Carcinoma - complications
Carcinoma - surgery
Care and treatment
CD4 antigen
Chi-square test
Complications
Demographics
Demography
Diagnosis
Health aspects
Highly active antiretroviral therapy
HIV
HIV - physiology
HIV Infections - complications
HIV Infections - surgery
HIV patients
Human immunodeficiency virus
Humans
Immune system
Laparoscopy
Laparoscopy - instrumentation
Laparoscopy - methods
Length of Stay - statistics & numerical data
Male
Medical examination
Middle Aged
Non-Hodgkin's lymphomas
original-article
Patient outcomes
Patients
Postoperative Complications - epidemiology
Prostate cancer
Prostatectomy
Prostatectomy - instrumentation
Prostatectomy - methods
Prostatic Neoplasms - complications
Prostatic Neoplasms - surgery
Risk factors
Robotic surgery
Robotics - methods
Robots
Statistical tests
Transfusion
Tumors
Urological surgery
Title Robot-assisted laparoscopic radical prostatectomy in men with human immunodeficiency virus
URI http://dx.doi.org/10.1038/pcan.2010.35
https://link.springer.com/article/10.1038/pcan.2010.35
https://www.ncbi.nlm.nih.gov/pubmed/20877308
https://www.proquest.com/docview/2645318547
https://www.proquest.com/docview/763333675
https://search.proquest.com/docview/764500683
https://search.proquest.com/docview/876223139
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEB6aBEovpU1fbraJDn2cTNaWJUunkoaEUEgooYGlFyPLMiwktrvrLfTfd8aWvZg02cMeVgOendFoPnleAB9V7lwkcPPG1rowcaUJtXUilIV2PFf4Q1fhfXklL26S7wux8Lk5a59WOZyJ3UFd1JbekR-jHeAH4e3X5ndIQ6MouOonaOzAXhwlFKXd-3Z29eN623U30vOh8CpVIvaZ73OujhvkvM_s6ia9bX2SP5mnjTUnwPNe0LTzRecv4LkHkeyk1_pLeOKqfXh66cPkr-DXdZ3XbYi4mJRYsFv0iNS1sm6Wlq1MF5phDdV7GIoh1Hd_2bJid65i9FqWdXP72JIqR-rCUYsJqs9kf5arzfo13Jyf_Ty9CP0QhdDiVaINy7xESBGXorSU8S8iK_FSgKiqzI00Ii2kVEbIQqApO6VMpJVN8M6mdZ6jIi1_A7tVXbl3wJKklLErhJkLdOxG6hKxQVyIlCtnlUgD-DSIMWv6XhlZF-PmKiNxZyTujIsAjkjGWV_pOZpYdkLYLuVa6QC-dBRkZO3KWONrBZAPalc1oZxNKNE47GQ56PU4MkSMEB_ExmxQbeYNd50hPhRUUJ7gvzm4vzzuwgDYuErPpFS1ytUbIkkEFd7wh0nIAyGu5sje235LjezF1KCRz1UAn4c9tn36_4T5_lE2D-BZPObfzGC3XW3cB0RRbX4IO-kixW91Gh16u_kH02kcoQ
link.rule.ids 315,786,790,12083,12250,21416,27955,27956,31752,31753,33299,33300,33777,33778,43343,43612,43838,74100,74369,74657
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEBZtCm0voe862TY69HEy2bUsWTqFEBq2bTaHkkDoRciyDAuJ7e56A_n3mZFlLyZt92gNeHZGo_nkeRHySebOzThs3sRaF6euNLGyjseiUI7lEh74Cu_FuZhfpj-u-FXIzVmHtMr-TPQHdVFb_EZ-CHYAP4C3R82fGIdGYXA1TNB4TJ6kDFw1FoqfbDM81ExN-7KrTPIk5L1PmTxsgO8ur8vPedt6pHAuj9tqjmDng5Cp90SnL8hugJD0uNP5S_LIVa_I00UIkr8mv3_Ved3GgIpRhQW9Bn-IPSvrZmnpyvjADG2w2sNgBKG-uaPLit64iuJHWeqn9tEl1o3UhcMGE1idSW-Xq836Dbk8_XZxMo_DCIXYwkWijcu8BECRlLy0mO_PZ1bAlQAwVZkbYXhWCCENFwUHQ3ZSmpmSNoUbm1J5Dmq07C3ZqerKvSc0TUuRuIKbKQe3boQqARkkBc-YdFbyLCKfezHqpuuUoX2Em0mN4tYobs14RA5Qxrqr8xwMTB8jssuYkioiXz0Fmli7MtaESgHgA5tVjSgnI0owDTtajjo9DgwhI8gHsjHpVauD2a41oEOO5eQp_Jv9h8vDHowIHVbxnZioVrl6gyQpx7Ib9m8S9D-Aqhmw967bUgN7CbZnZFMZkS_9Htu-_W_C3Psvmwfk2fxicabPvp__3CfPkyETZ0J22tXGfQA81eYfvdXcA9s1HD8
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96wuGL-G3vVi8PfjyV7TZNmjzJoS7nxx0iHiy-hDRNYMFr6273wP_emTbtUk7dx81ApzOZzC-dL0JeysK5BYfNm1rr4sx5EyvreCxK5Vgh4Y-uwvv8QpxdZp9WfBVaCm1DWuVwJnYHdVlb_EY-BzuAH8DbuQ9ZEV_fL982v2IcIIWB1jBN4za5A04ywSkO-Srf999dqGQowcolT0MOfMLkvIF36HO8uplve-8Uzuhpi80JBL0RPu280vI-uRfgJD3t9f-A3HLVQ3J4HgLmj8iPb3VRtzEgZFRnSX-Cb8T-lXWztnRjuiANbbDyw2A0ob76TdcVvXIVxQ-0tJvgR9dYQ1KXDptNYKUmvV5vdtvH5HL54fu7sziMU4gtXCra2BcewEXqubeY-88XVsD1APCVL4wwPC-FkIaLkoNROynNQkmbwe1NqaIAlVr2hBxUdeWeEZplXqSu5Cbh4OKNUB5QQlrynElnJc8j8moQo276rhm6i3YzqVHcGsWtGY_ICcpY9zWfo7HpU0R5OVNSReRNR4Hm1m6MNaFqAPjAxlUTytmEEszETpajXo8jQ8gI8oFszAbV6mDCWw1IkWNpeQZvc3xzedyPEaHjKj4Tk9YqV--QJONYgsP-TYK-CBA2A_ae9ltqZC_FVo0skRF5Peyx_dP_Jsyj_7J5Qg7BYPSXjxefj8nddEzKmZGDdrNzzwFatcWLzmj-AKAPIKA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Robot-assisted+laparoscopic+radical+prostatectomy+in+men+with+human+immunodeficiency+virus&rft.jtitle=Prostate+cancer+and+prostatic+diseases&rft.au=Silberstein%2C+J.L&rft.au=Parsons%2C+J.K&rft.au=Palazzi-Churas%2C+K&rft.au=Downs%2C+T.M&rft.date=2010-12-01&rft.pub=Nature+Publishing+Group&rft.issn=1365-7852&rft.eissn=1476-5608&rft.volume=13&rft.issue=4&rft.spage=328&rft_id=info:doi/10.1038%2Fpcan.2010.35&rft.externalDocID=A242373989
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1365-7852&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1365-7852&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1365-7852&client=summon